Tygh Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tygh Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-179,634	Closed	-$3.56M	–	104
2015 Q3	$3.56M	Sell	179,634 -189,987	-51%	-$6M	0.84%	54
2015 Q2	$12.8M	Sell	369,621 -81,982	-18%	-$2.5M	2.3%	1
2015 Q1	$11.7M	Buy	451,603 +56,773	+14%	+$1.04M	2.16%	3
2014 Q4	$5.09M	Buy	394,830 +85,367	+28%	+$1.07M	0.98%	47
2014 Q3	$3.8M	Buy	309,463 +64,989	+27%	+$755K	0.83%	58
2014 Q2	$3.87M	Buy	244,474 +115,489	+90%	+$1.65M	0.82%	55
2014 Q1	$1.95M	Buy	+128,985	New	+$1.46M	0.4%	90

Other funds holding HZNP

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return